Introduction
Tradename: Wyamine.
Indications
Dosage
30 mg IV every 5-10 min PRN
More general terms
Additional terms
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ 2.0 2.1 The Pharmacological Basis of Therapeutics, 8th ed. Gilman et al, eds. Permagon Press/McGraw Hill pg 189
- ↑ Deprecated Reference
Database